Jeffrey P. Shaw

3.2k total citations · 1 hit paper
26 papers, 2.4k citations indexed

About

Jeffrey P. Shaw is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jeffrey P. Shaw has authored 26 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Jeffrey P. Shaw's work include Chemokine receptors and signaling (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Metal-Catalyzed Oxygenation Mechanisms (3 papers). Jeffrey P. Shaw is often cited by papers focused on Chemokine receptors and signaling (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Metal-Catalyzed Oxygenation Mechanisms (3 papers). Jeffrey P. Shaw collaborates with scholars based in Switzerland, United States and United Kingdom. Jeffrey P. Shaw's co-authors include Shigeaki Harayama, Amanda E. I. Proudfoot, Timothy N. C. Wells, Dagmar Ringe, Gregory A. Petsko, Christopher Power, Matthias Schwarz, M Rekik, Thomas Rückle and Christian Rommel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Jeffrey P. Shaw

25 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis

2005 650 citations Montserrat Camps, Thomas Rückle et al. Nature Medicine profile →

Peers

Countries citing papers authored by Jeffrey P. Shaw

Since Specialization

Citations

This map shows the geographic impact of Jeffrey P. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey P. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey P. Shaw more than expected).

Fields of papers citing papers by Jeffrey P. Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey P. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey P. Shaw. The network helps show where Jeffrey P. Shaw may publish in the future.

Co-authorship network of co-authors of Jeffrey P. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey P. Shaw. A scholar is included among the top collaborators of Jeffrey P. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey P. Shaw. Jeffrey P. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Desmoplakin Cardiomyopathy Presenting as Recurrent Myocarditis Treated With Immunosuppression 2025 ·JACC Case Reports ·(unknown), (unknown), (unknown), Jeffrey P. Shaw, (unknown), James A. White, (unknown)	0
2	A knottin scaffold directs the CXC-chemokine–binding specificity of tick evasins 2019 ·Journal of Biological Chemistry ·Angela Lee, Maud Déruaz, (unknown), Graham Davies, (unknown), (unknown), (unknown), Akane Kawamura, Jeffrey P. Shaw, Amanda E. I. Proudfoot, (unknown), Shoumo Bhattacharya	25
3	Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display 2014 ·Journal of Biological Chemistry ·Pauline Bonvin, Steven M. Dunn, François Rousseau, Douglas P. Dyer, Jeffrey P. Shaw, Christopher Power, Tracy M. Handel, Amanda E. I. Proudfoot	23
4	CHARACTERIZING TYPE 17 IMMUNE RESPONSES IN ANKYLOSING SPONDYLITIS 2013 ·Lara D. Veeken ·Hussein Al‐Mossawi, Anne J. Ridley, (unknown), Simon Kollnberger, Jeffrey P. Shaw, Paul Bowness	1
5	The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors 2010 ·Nature Chemical Biology ·Alex Berndt, Simon Miller, Olusegun Williams, Daniel D. Le, Benjamin T. Houseman, Joseph I. Pacold, F. Gorrec, Wai‐Ching Hon, Pingda Ren, Yi Liu, Christian Rommel, P. Gaillard, Thomas Rückle, Matthias Schwarz, Kevan M. Shokat, Jeffrey P. Shaw, Roger Williams	215
6	Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3 2009 ·PLoS ONE ·(unknown), Christophe Losberger, Maud Déruaz, Christopher Power, Amanda E. I. Proudfoot, Jeffrey P. Shaw	44
7	Ticks produce highly selective chemokine binding proteins with antiinflammatory activity 2008 ·The Journal of Experimental Medicine ·Maud Déruaz, (unknown), Ana L. Alessandri, (unknown), Fernanda M. Coelho, Remo Castro Russo, Beatriz Rossetti Ferreira, Gerard J. Graham, Jeffrey P. Shaw, Timothy N. C. Wells, Mauro Martins Teixeira, Christopher Power, Amanda E. I. Proudfoot	168
8	Protein therapeutics – lessons learned and a view of the future 2005 ·Expert Opinion on Biological Therapy ·Caroline Johnson‐Léger, Christopher Power, (unknown), Jeffrey P. Shaw, (unknown)	19
9	Chemokine blockers – therapeutics in the making? 2005 ·Trends in Pharmacological Sciences ·Timothy N. C. Wells, Christopher Power, Jeffrey P. Shaw, Amanda E. I. Proudfoot	133
10	Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis breakdown → 2005 ·Nature Medicine ·Montserrat Camps, Thomas Rückle, Hong Ji, (unknown), Felix Rintelen, Jeffrey P. Shaw, Chiara Ferrandi, Christian Chabert, Corine Gilliéron, (unknown), Thierry Martin, Denise Gretener, Dominique Perrin, Didier Leroy, Pierre‐Alain Vitte, Emilio Hirsch, Matthias P. Wymann, R Cirillo, Matthias Schwarz, Christian Rommel	650
11	The X-Ray Structure of RANTES 2004 ·Structure ·Jeffrey P. Shaw, Zoë Johnson, Frédéric Borlat, Catherine Zwahlen, Andreas J. Kungl, Karen Roulin, Axel Harrenga, Timothy N. C. Wells, Amanda E. I. Proudfoot	82
12	The BBXB Motif of RANTES Is the Principal Site for Heparin Binding and Controls Receptor Selectivity 2001 ·Journal of Biological Chemistry ·Amanda E. I. Proudfoot, Sarah Fritchley, Frédéric Borlat, Jeffrey P. Shaw, Francis Vilbois, Catherine Zwahlen, Alexandra Trkola, David Marchant, Paul R. Clapham, Timothy N. C. Wells	211
13	Substrate Recognition Domains within Extracellular Signal-regulated Kinase Mediate Binding and Catalytic Activation of Mitogen-activated Protein Kinase Phosphatase-3 2000 ·Journal of Biological Chemistry ·Anthony C. Nichols, Montserrat Camps, Corine Gilliéron, Christian Chabert, Anne Brunet, Julie L. Wilsbacher, Melanie H. Cobb, Jacques Pouysségur, Jeffrey P. Shaw, Steve Arkinstall	84
14	Characterization in vitro of the hydroxylase component of xylene monooxygenase, the first enzyme of the TOL-plasmid-encoded pathway for the mineralization of toluene and xylenes 1995 ·Journal of Fermentation and Bioengineering ·Jeffrey P. Shaw, Shigeaki Harayama	20
15	Overlapping substrate specificities of benzaldehyde dehydrogenase (the xylC gene product) and 2-hydroxymuconic semialdehyde dehydrogenase (the xylG gene product) encoded by TOL plasmid pWW0 of Pseudomonas putida 1995 ·Journal of Bacteriology ·Jun Inoue, Jeffrey P. Shaw, M Rekik, Shigeaki Harayama	50
16	Crystallization and Preliminary X-ray Diffraction Studies of Human RANTES 1994 ·Journal of Molecular Biology ·Jeffrey P. Shaw, Gitay Kryger, (unknown), Alan J. Wonacott, Christopher Power, Amanda E. I. Proudfoot, Timothy N. C. Wells	2
17	Purification and characterisation of the NADH: acceptor reductase component of xylene monooxygenase encoded by the TOL plasmid pWWO of Pseudomonas putida mt‐2 1992 ·European Journal of Biochemistry ·Jeffrey P. Shaw, Shigeaki Harayama	48
18	Primary structure of xylene monooxygenase: similarities to and differences from the alkane hydroxylation system 1991 ·Journal of Bacteriology ·Mikiko Suzuki, Tomoaki Hayakawa, Jeffrey P. Shaw, M Rekik, Shigeaki Harayama	145
19	Purification and characterisation of TOL plasmid‐encoded benzyl alcohol dehydrogenase and benzaldehyde dehydrogenase of Pseudomonas putida 1990 ·European Journal of Biochemistry ·Jeffrey P. Shaw, Shigeaki Harayama	68
20	Synthesis Of Oligodeoxyribonucleotides Containing an Aliphatic Amino Linker Arm at Selected Adenine Bases and Derivatization with Biotin 1987 ·Nucleosides and Nucleotides ·Jean‐Paul Roduit, Jeffrey P. Shaw, (unknown), André Chollet	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact